MentionFox
Home › funding signals › NeuroBionics Inc.
Form D · on the record

NeuroBionics Inc. — $4.25M Form D filing, December 2025

NeuroBionics Inc. filed a Form D with the Securities and Exchange Commission on 2025-12-10.

NeuroBionics Inc. filed a Form D notice of an exempt securities offering with the SEC on December 10, 2025. The filing reports $4.25M sold. Its industry group is Other Technology. It names Marc-Joseph Antonini (Executive Officer, Director), Nicolette Driscoll (Executive Officer, Director), Polina Anikeeva (Director) (SEC Form D, December 10, 2025).

5 more Other Technology raises in Massachusetts, December 2025 ↓

Sell to companies like NeuroBionics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

Run the free check on NeuroBionics Inc. →

NeuroBionics Inc.

New Form D on file · 2025-12-10 · the record

$4.25M
raise on the record
D
filing
7
investors in
MASSACHUSETTS
based
Open the record →

What the record says

FilingForm D
Filed2025-12-10
Industry groupOther Technology
Entity typeCorporation
Incorporated inDELAWARE
Year formed2023
BasedSOMERVILLE, MASSACHUSETTS
CIK2100415
Accession0002100415-25-000001

Pitching, partnering or investing alongside them? See who really runs and owns NeuroBionics Inc.

Watch NeuroBionics Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind NeuroBionics Inc., from the filings we hold.

More raises like this

Other Technology raises by companies based in Massachusetts, filed in December 2025, largest first.

What do you want to do with NeuroBionics Inc.?

Get the full cited report on NeuroBionics Inc.

What the filing shows about NeuroBionics Inc.

  • The filing reports $540K of the proceeds going to the company's own executives, directors or promoters.
  • 7 investors had already put money in when it filed.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on NeuroBionics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

What the filing says

  • Offered: $4,249,990. Sold: $4,249,990. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 7 had already invested. (filing)
  • Date of first sale: November 25, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16, payments to executive officers, directors or promoters: $540,000 of the proceeds is used or proposed to be used for such payments. The filing explains: “The invested funds are being used to fund working capital. The payment described in this Item 16 include only salary payments to the executive officers described in Item 3, above.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on NeuroBionics Inc. See pricing

Other Technology · by week
This raise, $4.25M, filed week of Dec 8

Trailing twelve months. 3831 filings in Other Technology, totalled by week. The dot is this raise, $4.25M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on NeuroBionics Inc.?

What the filing shows about NeuroBionics Inc.

  • The filing reports $540K of the proceeds going to the company's own executives, directors or promoters.
  • 7 investors had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on NeuroBionics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on NeuroBionics Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind NeuroBionics Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for NeuroBionics Inc.. With no account yet, you sign up free and land on the result.

Share this page

Just raised? Share it.

NeuroBionics Inc.: Raised $4.25M, Form D filed 2025-12-10

Cite this page

Permanent URL: https://mentionfox.com/funding/neurobionics-inc-form-d-25000001
Last updated 2026-10-27
Primary record: SEC filing 1 · SEC filing 2
NeuroBionics Inc. raised $4.25M — SEC Form D filing, December 2025. MentionFox, 2026-10-27. https://mentionfox.com/funding/neurobionics-inc-form-d-25000001